Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients.

Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients.

BACKGROUND: Various studies have been searching for new tumor biomarkers for breast cancer for years. However, so far, few markers have been proved clinically useful except CA153. Based on knowledge that most adenocarcinomas including breast carcinoma expressed Cytokeratin19, the authors studied CK1...

Full description

Bibliographic Details
Main Authors: Yanan Kong, Junye Wang, Wanli Liu, Qiaolun Chen, Juan Yang, Weidong Wei, Mingqing Wu, Lu Yang, Xinhua Xie, Ning Lv, Jiaoli Guo, Laisheng Li, Jie Gao, Xiaoming Xie, Shuqin Dai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3585311?pdf=render

Internet

http://europepmc.org/articles/PMC3585311?pdf=render

Similar Items